Post-Marketing Clinical Study of Ravulizumab in Participants With Clinical aHUS
Clinical trial NCT07308574 · RECRUITING
Trial details
- NCT number
- NCT07308574
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-19
- Primary completion
- 2027-06-25
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.